Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
Open Forum Infectious Diseases
|
December 14, 2019
Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients
Flaminia Olearo, Huyen Nguyen, Fabrice Bonnet, et al.
BMJ Open
|
November 13, 2020
Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trial
Mikaela Smit, Annalisa Marinosci, Giovanni Jacopo Nicoletti, et al.
Open Forum Infectious Diseases
|
October 30, 2019
Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients
Flaminia Olearo, Huyen Nguyen, Fabrice Bonnet, et al.
Open Forum Infectious Diseases
|
September 23, 2022
Anticholinergic and Sedative Medications Are Associated With Neurocognitive Performance of Well Treated People With Human Immunodeficiency Virus
Bernadette Jakeman, Alexandra U Scherrer, Katharine E A Darling, et al.
Plos One
|
March 2, 2021
Alcohol consumption and neurocognitive deficits in people with well-treated HIV in Switzerland
Katharine E A Darling, Isabella Locatelli, Nadia Benghalem, et al.
Pharmaceutics
|
August 26, 2022
Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland
Paul Thoueille, Susana Alves Saldanha, Fabian Schaller, et al.
The Journal of Antimicrobial Chemotherapy
|
February 4, 2023
Frequency matters: comparison of drug resistance mutation detection by Sanger and next-generation sequencing in HIV-1
Suraj Balakrishna, Tom Loosli, Maryam Zaheri, et al.
Swiss Medical Weekly
|
August 10, 2021
Ninety-day outcome of patients with severe COVID-19 treated with tocilizumab - a single centre cohort study
Mihaela Sava, Gregor Sommer, Thomas Daikeler, et al.
International Journal of Epidemiology
|
August 7, 2021
Cohort Profile Update: The Swiss HIV Cohort Study (SHCS)
Alexandra U Scherrer, Anna Traytel, Dominique L Braun, et al.
Swiss Medical Weekly
|
June 27, 2022
Changes in mental and sexual health among MSM using HIV pre-exposure prophylaxis during the SARS-CoV-2 pandemic: longitudinal analysis of the SwissPrEPared cohort study
Babette L Winter, Frédérique Hovaguimian, Roger D Kouyos, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
Open Forum Infectious Diseases
|
December 14, 2019
Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients
Flaminia Olearo, Huyen Nguyen, Fabrice Bonnet, et al.
BMJ Open
|
November 13, 2020
Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trial
Mikaela Smit, Annalisa Marinosci, Giovanni Jacopo Nicoletti, et al.
Open Forum Infectious Diseases
|
October 30, 2019
Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients
Flaminia Olearo, Huyen Nguyen, Fabrice Bonnet, et al.
Open Forum Infectious Diseases
|
September 23, 2022
Anticholinergic and Sedative Medications Are Associated With Neurocognitive Performance of Well Treated People With Human Immunodeficiency Virus
Bernadette Jakeman, Alexandra U Scherrer, Katharine E A Darling, et al.
Plos One
|
March 2, 2021
Alcohol consumption and neurocognitive deficits in people with well-treated HIV in Switzerland
Katharine E A Darling, Isabella Locatelli, Nadia Benghalem, et al.
Pharmaceutics
|
August 26, 2022
Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland
Paul Thoueille, Susana Alves Saldanha, Fabian Schaller, et al.
The Journal of Antimicrobial Chemotherapy
|
February 4, 2023
Frequency matters: comparison of drug resistance mutation detection by Sanger and next-generation sequencing in HIV-1
Suraj Balakrishna, Tom Loosli, Maryam Zaheri, et al.
Swiss Medical Weekly
|
August 10, 2021
Ninety-day outcome of patients with severe COVID-19 treated with tocilizumab - a single centre cohort study
Mihaela Sava, Gregor Sommer, Thomas Daikeler, et al.
International Journal of Epidemiology
|
August 7, 2021
Cohort Profile Update: The Swiss HIV Cohort Study (SHCS)
Alexandra U Scherrer, Anna Traytel, Dominique L Braun, et al.
Swiss Medical Weekly
|
June 27, 2022
Changes in mental and sexual health among MSM using HIV pre-exposure prophylaxis during the SARS-CoV-2 pandemic: longitudinal analysis of the SwissPrEPared cohort study
Babette L Winter, Frédérique Hovaguimian, Roger D Kouyos, et al.
Page
of 8